Standout Papers
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations (2018)
- The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups (2012)
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer (2011)
- Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells (2024)
- Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy (2025)
Immediate Impact
9 by Nobel laureates 14 from Science/Nature 81 standout
Citing Papers
Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
2023 Standout
Screening for Lung Cancer
2021 Standout
Works of Ravi Salgia being referenced
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups
2012 Standout
Lung carcinoma in African Americans
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ravi Salgia | 10406 | 12218 | 8256 | 618 | 26.9k | |
| Godefridus J. Peters | 16248 | 17685 | 5349 | 844 | 34.4k | |
| Peter J. O’Dwyer | 12800 | 9732 | 5123 | 394 | 23.0k | |
| Alex A. Adjei | 11339 | 12744 | 8009 | 467 | 25.6k | |
| Elizabeth A. Eisenhauer | 15013 | 11776 | 12565 | 205 | 41.1k | |
| Éric Raymond | 10556 | 8626 | 4391 | 364 | 20.8k | |
| Howard A. Burris | 25010 | 12786 | 10502 | 737 | 37.4k | |
| William D. Figg | 9855 | 11342 | 4342 | 599 | 24.6k | |
| Setsuo Hirohashi | 8598 | 15216 | 4262 | 441 | 28.1k | |
| Eric K. Rowinsky | 18262 | 11946 | 9456 | 392 | 31.5k | |
| Hiroyuki Aburatani | 8249 | 23941 | 5940 | 525 | 37.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...